Abstract
Background: Decreased heart rate recovery (HRR) is a predictor of mortality in patients with coronary artery disease and preserved left ventricular function. We investigated the changes in HRR and assessed the impact of β-blockade therapy on these parameters in patients with symptomatic congestive heart failure (CHF). Methods and Results: HRR, defined as the difference from peak exercise heart rate (HR) to HR measured at 1, 2, and 3 minutes after maximal exercise test, was studied in 23 stable CHF patients and 12 healthy subjects. Patients with CHF performed a maximal exercise test using a Ramp protocol before and after 6 months of therapy with either metoprolol or carvedilol. Patients with CHF exhibited a significantly attenuated HRR compared with healthy subjects at 1 minute (17.8 ± 5.8 versus 26.8 ± 16.2 beats), 2 minutes (34.0 ± 10.6 versus 48.0 ± 11.2 bpm) and 3 minutes (41.0 ± 12.4 versus 60.0 ±12.4 bpm) after exercise (P <.05 for all parameters). β-blocker therapy for 6 months did not significantly improve HRR. Conclusion: HRR is markedly attenuated in stable CHF patients compared with healthy subjects. Long-term β-blocker therapy appears to cause no significant improvement in HRR up to 3 minutes after maximal exercise.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
